Mangrove Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-310,000
Closed -$5.44M 652
2021
Q3
$5.44M Buy
+310,000
New +$5.44M 0.49% 33